FDA Approves New Treatment for Hemophilia A or B ...Middle East

PR Newswire - News
FDA Approves New Treatment for Hemophilia A or B
Product is First Non-Factor and Once-Weekly Treatment for Hemophilia B SILVER SPRING, Md., Oct. 11, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in...

Hence then, the article about fda approves new treatment for hemophilia a or b was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves New Treatment for Hemophilia A or B )

Apple Storegoogle play

Last updated :

Also on site :



Latest News